Literature DB >> 8723962

Craniometaphyseal dysplasia: operative findings and treatment.

D C Franz1, K L Horn, J Aase.   

Abstract

Craniometaphyseal dysplasia (CMD) is a genetic bone disorder involving an abnormality of modeling of the long bones and sclerosis of the cranium. Both conductive and sensorineural hearing may be frequently associated with this syndrome. Conductive hearing loss is due to attic fixation of the lateral ossicular chain and hyperostosis formation with stapes ankylosis. Two patients with CMD were treated surgically. Two of three ears operated on had closure of the air-bone gap, whereas the third ear failed ossicular reconstruction because of hyperostosis of the promontory with deepening of the oval window.

Entities:  

Mesh:

Year:  1996        PMID: 8723962

Source DB:  PubMed          Journal:  Am J Otol        ISSN: 0192-9763


  4 in total

1.  A Phe377del mutation in ANK leads to impaired osteoblastogenesis and osteoclastogenesis in a mouse model for craniometaphyseal dysplasia (CMD).

Authors:  I-Ping Chen; Liping Wang; Xi Jiang; Hector Leonardo Aguila; Ernst J Reichenberger
Journal:  Hum Mol Genet       Date:  2010-12-13       Impact factor: 6.150

2.  Induced pluripotent stem cell reprogramming by integration-free Sendai virus vectors from peripheral blood of patients with craniometaphyseal dysplasia.

Authors:  I-Ping Chen; Keiichi Fukuda; Noemi Fusaki; Akihiro Iida; Mamoru Hasegawa; Alexander Lichtler; Ernst J Reichenberger
Journal:  Cell Reprogram       Date:  2013-11-12       Impact factor: 1.987

3.  Dental Anomalies Associated with Craniometaphyseal Dysplasia.

Authors:  I-P Chen; A Tadinada; E H Dutra; A Utreja; F Uribe; E J Reichenberger
Journal:  J Dent Res       Date:  2014-03-24       Impact factor: 6.116

4.  Rapid degradation of progressive ankylosis protein (ANKH) in craniometaphyseal dysplasia.

Authors:  Jitendra Kanaujiya; Edward Bastow; Raj Luxmi; Zhifang Hao; Dimitrios Zattas; Mark Hochstrasser; Ernst J Reichenberger; I-Ping Chen
Journal:  Sci Rep       Date:  2018-10-24       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.